Atb Cap Markets Analysts Lift Earnings Estimates for Jushi

Key Points

• Atb Cap Markets has revised its Q3 2025 earnings per share estimate for Jushi Holdings to ($0.05), an improvement from the previous estimate of ($0.06).
• The company reported revenues of $65.05 million in its last quarterly earnings, inching above the consensus estimate of $64.67 million.
• Jushi has a 52-week stock range between $0.22 and $0.69, with its current share price at $0.63.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Research analysts at Atb Cap Markets lifted their Q3 2025 earnings estimates for Jushi in a research report issued on Tuesday, August 5th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($0.05) per share for the quarter, up from their prior forecast of ($0.06). The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi's Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.26) EPS and FY2026 earnings at ($0.19) EPS.

Jushi Stock Performance

Shares of JUSHF traded up $0.04 during mid-day trading on Friday, hitting $0.68. 398,505 shares of the company were exchanged, compared to its average volume of 417,583. Jushi has a 1-year low of $0.22 and a 1-year high of $0.73. The company has a 50 day moving average of $0.40 and a 200-day moving average of $0.35. The stock has a market cap of $133.10 million, a price-to-earnings ratio of -2.33 and a beta of -0.98.

Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The firm had revenue of $65.05 million for the quarter, compared to analysts' expectations of $64.67 million.

About Jushi

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.